KAII, a putative marker for metastatic potential in human breast cancer

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 149-155

  Yang, Xiaohong ^a   Welch, Danny R ^b   Phillips, Karen K ^c   Weissman, Bernard E ^c   Wei, Lisa L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Human breast cancer; KAII; Metastasis; Prognostic marker; Tumor progression

Indexed keywords

MESSENGER RNA; CD82 ANTIGEN; KAI1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CELL IMMORTALIZATION; CELL LINE; CHROMOSOME 11; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; METASTASIS POTENTIAL; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CHROMOSOME MAP; GENETIC MARKER; METABOLISM; PATHOLOGY;

ANTIGENS, CD; BREAST NEOPLASMS; CHROMOSOME MAPPING; GENETIC MARKERS; HUMANS; KANGAI-1 PROTEIN; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0030609204     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00273-5     Document Type: Article

References (22)

1. P. Pisani, D.M. Parkin, J. Ferlay, Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden, Int. J. Cancer 55 (1993) 891-903.
2. T. Sato, A. Tanigami, K. Yamakawa, F. Akiyama, F. Kasumi, G. Sakamoto, Y. Nakamura, Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer, Cancer Res. 50 (1990) 7814-7819.
3. L.A. Liotta, Cancer cell invasion and metastasis, Sci. Am. 266 (2) (1992) 54-59.
4. T.N. Dear, R.F. Kefford, Molecular oncogenetics of metastasis and angiogenesis, Mol. Aspects Med. 11 (1990) 243-324.
5. L.A. Liotta, P.S. Steeg, W.G. Stetler-Stevenson, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell 64 (1991) 327-336.
6. K.K. Phillips, D.R. Welch, M.E. Miele, J.-H. Lee, L.L. Wei, B.E. Weissman, Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11, Cancer Res. 56 (1996) 1222-1227.
7. V. Van Heyningen, P.F.R. Little, Report of the fourth international workshop on human chromosome 11 mapping, Cytogenet. Cell Genet. 69 (1994) 128-158.
8. C.W. Rinker-Schaeffer, A.L. Hawkins, N. Ru, J. Dong, G. Stoica, C.A. Griffin, T. Ichikawa, J.C. Barrett, J.T. Isaacs, Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11, Cancer Res. 54 (23) (1994) 6249-6256.
9. J.-T. Dong, P.W. Lamb, C.W. Rinker-Schaeffer, J. Vukanovic, T. Ichikawa, J.T. Isaacs, J.C. Barrett, KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2, Science 268 (1995) 884-886.
10. M. Adachi, T. Taki, Y. Ieki, C.-L. Huang, M. Higashiyama, M. Miyake, Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer, Cancer Res. 56 (1996) 1751-1755.
11. X. Guo, H. Friess, H.U. Graber, M. Kashiwagi, A. Zimmermann, M. Korc, KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases, Cancer Res. 56 (1996) 4876-4880.
12. J.-T. Dong, H. Suzuki, S.S. Pin, S.B. Bova, J.A. Schalken, W.B. Isaacs, J.C. Barrett, J.T. Isaacs, Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss, Cancer Res. 56 (1996) 4387-4390.
13. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D.Peterson Jr., , R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, S.C. Brooks, Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10, Cancer Res. 50 (18) (1990) 6075-6086.
14. D. Elashry-Stowers, D.T. Zava, W.C. Speers, D.P. Edwards, Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies, Cancer Res. 48 (22) (1988) 6462-6474.
15. J.E. Price, A. Polyzos, R.D. Zhang, L.M. Daniels, Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice, Cancer Res. 50 (1990) 717-721.
16. E.W. Thompson, S. Paik, N. Brunner, C.L. Sommers, G. Zugmaier, R. Clarke, T.B. Shima, J. Torri, S. Donahue, M.E. Lippman, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines, J. Cell. Physiol. 150 (1992) 534-544.
17. L.L. Wei, N.L. Krett, M.D. Francis, D.F. Gordon, W.M. Wood, B.W. O'Malley, K.B. Horwitz, Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells, Mol. Endocrinol. 2 (1988) 67-72.
18. M.J. Pilat, J.K. Christman, S.C. Brooks, Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6, Breast Cancer Res. Treat. 37 (1996) 253-266.
19. M.D. Wright, M.G. Tomlinson, The ins and outs of the transmembrane 4 superfamily, Immunol. Today 15 (12) (1994) 588-594.
20. M. Miyake, K. Nakano, Y. Ieki, M. Adachi, C.-L. Huang, S. Itoi, T. Koh, T. Taki, Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer, Cancer Res. 55 (1995) 4127-4131.
21. M. Higashiyama, T. Taki, Y. Ieki, M. Adachi, C-L. Huang, T. Koh, K. Kodama, O. Doi, M. Miyake, Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer, Cancer Res. 55 (1995) 6040-6044.
22. S. Ikeyama, M. Koyama, M. Yamaoko, R. Sasada, M. Miyake, Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA, J. Exp. Med. 177 (1993) 1231-1237.